Day One

Tuesday 10 June, 2025

8:00 am Check-In + Badge Collection + Light Breakfast

8:50 am Chair’s Opening Remarks

Maximizing Data Quality to Enhance Quality of RWE

9:00 am Timely, Tested, Trusted: Proactively Generating Robust RWD Insights

  • Luke McGuinness Senior Manager, Real World Science, Alexion Pharmaceuticals

Synopsis

  • Leverage insights from past analyses to develop future-focused RWD analysis strategy
  • Deploy data pipelines and automation to efficiently deliver robust RWD insights across indications
  • Build trust with cross-functional stakeholders through proactive communication of RWD insights

9:30 am Addressing Data Representativeness & Relevance to Improve the Applicability of RWE to Support Policy Decisions

Synopsis

  • Examine approaches to mitigate biases and enhance the inclusivity of datasets to better reflect diverse patient populations
  • Understand how to tailor real-world evidence to meet the specific requirements of policymakers and regulatory bodies
  • Explore methods to identify and prioritize data sources that align with current healthcare challenges and decision-making frameworks

10:00 am Building Trust in (RWE) With a Focus on UK & Nordic Data Sources in Reference to EU/EMA & NICE Guidelines for RWE

Synopsis

  • Face validity of secondary health data
  • Validation studies & disease algorithm development
  • Transparency and public trust in the use of health data

10:30 Speed Networking

Synopsis

This session is a great opportunity to introduce yourself to the attendees that you would like to have more in depth conversations with. This session is the ideal opportunity to get face-to-face time with many of the real-world evidence experts to stablish meaningful business relationships.

11:00 Morning Break

Consolidating Cross-Functional Collaboration to Improve Effectiveness & Efficiency of RWE Studies

11:30 am Cross-Functional Collaboration Techniques to Improve Coordination Between R&D, Market Access, & Regulatory Teams

  • Swarna Khare Director - Immunology & Real World Evidence, Novartis AG

Synopsis

  • Explore strategies to establish clear and consistent communication pathways between R&D, market access, and regulatory teams to align goals and timelines
  • Learn best practices for sharing real-time data and insights across functions to drive informed decision-making and streamline development processes
  • Discover how to foster a collaborative culture, ensuring that all teams work together efficiently towards common objectives, from early development through to market access

12:00 pm Elevating Strategic Collaboration Between Global and Local Teams to Enhance Coordination & Efficiency in Evidence Generation

  • Tina Roblek Evidence Generation & Management Lead Managed Care Organization & Electrical Engineering, Takeda Pharmaceutical

Synopsis

  • Explore strategies for aligning global and local teams to ensure consistency in evidence generation while addressing regional needs and regulatory requirements
  • Learn how to streamline communication and workflows between global and local teams to enhance efficiency and reduce duplication in evidence generation efforts
  • Discover techniques for incorporating local data and patient insights into global evidence strategies to ensure broader relevance and applicability

12:30 Lunch

1:30 pm Roundtable: Strategies for Operationalizing JCA Requirements Through Practical Steps to Integrate JCA Processes into Your Organization

Synopsis

  • Break down the Joint Clinical Assessment (JCA) requirements to understand their implications for evidence generation and submission
  • Explore actionable steps to align organizational workflows, timelines, and resources with JCA standards and expectations
  • Learn how to foster collaboration between regulatory, clinical, and market access teams to streamline JCA integration and ensure compliance

2:00 pm Strategic & Practical Execution of RWE Tactics to Advance Cross- Functional Collaboration

  • Maurice Timmermans Head Procurement Real World Evidence Generation & Dissemination, Astellas Pharma

Synopsis

  • Navigating issues when working with medical affairs teams and vendors
  • Proposed business case to improve Approach to RWE
  • Case study led insights

2:30 pm Afternoon Break & Poster Session

Synopsis

Witness some of the latest and greatest research in the RWE and evidence generation field by drug developers, academics, and researchers in this spotlight poster session!

3:00 pm Breaking Down Silos for Optimized & Impactful Integrated Evidence Generation

Synopsis

  • Explore strategic partnership to enhance the IEG plan
  • Understand the value of creating a culture of collaboration to enhance the impact and effectiveness of RWE
  • Challenges with implicating these strategies into a workflow

3:30 pm From Challenges to Best Practices in Conducting Multi-Center Secondary Data Research with OMOP CDM

Synopsis

  • Must-haves for future-proof medical evidence generation.
  • Fit-for-purpose data, data infrastructure and governance.
  • Examples from case studies in oncology

4:00 pm Chair’s Closing Remarks